Tehran University of Medical Sciences

Science Communicator Platform

Share By
Damage-Associated Molecular Patterns in Tumor Radiotherapy Publisher Pubmed



Ashrafizadeh M1 ; Farhood B2 ; Eleojo Musa A3 ; Taeb S4 ; Najafi M5
Authors

Source: International Immunopharmacology Published:2020


Abstract

Radiotherapy is one of the most common modalities for the treatment of cancer. One of the most promising effects of radiotherapy is immunologic cell death and the release of danger alarms, which are known as damage-associated molecular patterns (DAMPs). DAMPs are able to trigger cancer cells and other cells within tumor microenvironment (TME), either for suppression or promotion of tumor growth. Heat shock proteins (HSPs) including HSP70 and HSP90, high mobility group box 1 (HMGB1), and adenosine triphosphate (ATP) and its metabolites such as adenosine are the most common danger alarms that are released after radiotherapy-induced immunologic cell death. Some DAMPs including adenosine is able to interact with both cancer cells as well as other cells in TME to promote tumor growth and resistance to radiotherapy. However, others are able to trigger anti-tumor immunity or both tumor suppressive and immunosuppressive mechanisms depending on affected cells. In this review, we explain the mechanisms behind the release of radiation-induced DAMPs, and its consequences on cells within tumor. Targeting of these mechanisms may be in favor of tumor control in combination with radiotherapy and radioimmunotherapy. © 2020 Elsevier B.V.
1. Radiation and Immunity: Hand in Hand From Tumorigenesis to Therapeutic Targets, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
Experts (# of related papers)
Other Related Docs
8. New Approaches in Cancer Immunotherapy: Review Article, Tehran University Medical Journal (2018)
16. Immunotherapeutic Approaches for Cancer Therapy: An Updated Review, Artificial Cells# Nanomedicine and Biotechnology (2016)
18. Cancer Immunotherapy Confers a Global Benefit, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
19. Immunoregulation by Resveratrol; Implications for Normal Tissue Protection and Tumour Suppression, Clinical and Experimental Pharmacology and Physiology (2023)
20. Cancer Immunotherapy Confers a Global Benefit, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2015)